INTELLIGENCE IN ACTION

Spotlight on Technologies to Help Address the Opioid Crisis

May 01, 2018

In 2016, 42,200 Americans, or nearly five people every hour, died from opioid-related overdose. And according to a 2017 Council of Economic Advisers report, the opioid epidemic cost the nation $504 billion in economic losses in 2015, or 2.8 percent of the GDP that year.




In fact, the opioid crisis ranks as the greatest public health emergency we have faced since the AIDS epidemic, with more deaths from drug overdoses in 2015 than from AIDS when it reached its peak in the mid-1990s.

In his new paper, “Changing the Course of the Opioid Epidemic: The Power and Promise of Proven Technology,” Paul Uhrig, Surescripts Chief Administrative, Legal and Privacy Officer, outlines how technology can help address two key challenges of the opioid epidemic: drug diversion, including the illegal use of prescription opioids, and clinical appropriateness, including effective uses of opioids for patients with legitimate needs.

“Technology can help fight the opioid epidemic, but only when it’s deployed and used in the course of delivering care.”

As Paul states, “Technology can help fight the opioid epidemic, but only when it’s deployed and used in the course of delivering care. In its absence, clinicians and prescribers are robbed of crucial insights and forced to forage for data manually—trying to make optimal care decisions and deliver adequate pain management without the best intelligence to do so.” 

The opioid crisis calls on the healthcare industry to bring a variety of tools and resources to the forefront. This includes building industrywide awareness of the powerful and promising technologies that are available right now. These technologies can support healthcare professionals who are on the front line by informing their care decisions with more actionable intelligence at the point of care.

Download the paper to learn more about the technologies that can help.

2018_06_OpioidsPositionPaper

Related Articles

November 11, 2019

50 Days and Counting: Take These Necessary Steps to Meet EPCS Requirements

Fraud and abuse are prevalent in the world of prescription painkillers. In 2017, a total of 61,311 people died from drug overdoses – with an estimated 40% from prescription opioid medicine. This is 61,311 too many. Opioid diversion is a significant cause of opioid misuse, with between 3% and 9% of diverted drugs tied to fraud or forgery of paper prescriptions.

Read more...
October 22, 2019

Now Trending: EPCS Among Physicians and Medicare Part D Patients

As we approach the one-year anniversary of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act, I am optimistic about the direction of a key provision outlined in the legislation, that is, the use of electronic prescribing of controlled substance (EPCS) among Medicare Part D providers.  Read more...
July 30, 2019

Lessons Learned: How Connecticut Implemented an EPCS Requirement That Was Effective and Embraced by the Medical Community

Connecticut’s Electronic Prescribing of Controlled Substances (EPCS) requirement came into effect in January 2018. As Drug Control Director, I often serve as an advisor to state legislators who want to ensure the bills they draft are effective once they become law, so I was very active in the 2017 legislative session. While crafting this bill, we looked at how other states managed implementation of EPCS and worked closely with medical professionals to ensure that our legislation was thoughtful. We knew we had to consider the day-to-day operations of regulators and medical professionals, and ultimately what was best for patients.

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX